Arnold Susan Elizabeth

CIK 00017557461 companyMALVERN, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001755746

Recent Transactions

20 trades

Award
PhaseBio Pharmaceuticals Inc
Common Stock
2022-05-20$0.68/sh+10,917→ 41,236 total
Award
PhaseBio Pharmaceuticals Inc
Restricted Stock Unit
2022-02-24+18,750→ 18,750 total
Award
PhaseBio Pharmaceuticals Inc
Employee Stock Option (right to buy)
2022-02-24+87,500→ 87,500 total
Award
PhaseBio Pharmaceuticals Inc
Common Stock
2021-11-19$2.01/sh+2,559→ 30,319 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Employee Stock Option (right to buy)
2021-07-12−4,519→ 0 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2021-07-12$1.74/sh+4,519→ 27,760 total
Award
PhaseBio Pharmaceuticals Inc
Common Stock
2021-07-12$1.74/sh+4,519→ 27,760 total
Award
PhaseBio Pharmaceuticals Inc
Common Stock
2021-05-20$2.80/sh+5,257→ 23,241 total
Award
PhaseBio Pharmaceuticals Inc
Employee Stock Option (right to buy)
2021-02-05+36,000→ 36,000 total
Award
PhaseBio Pharmaceuticals Inc
Common Stock
2020-11-20$3.00/sh+4,832→ 17,984 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2020-10-01$1.15/sh+5,423→ 13,152 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Employee Stock Option (right to buy)
2020-10-01$1.15/sh−5,423→ 0 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Employee Stock Option (right to buy)
2020-02-27$1.15/sh−5,423→ 0 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2020-02-27$1.15/sh+5,423→ 7,729 total
Award
PhaseBio Pharmaceuticals Inc
Employee Stock Option (right to buy)
2020-02-12+55,000→ 55,000 total
Award
PhaseBio Pharmaceuticals Inc
Employee Stock Option (right to buy)
2019-02-27+45,000→ 45,000 total
Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2018-10-22+2,306→ 2,306 total
Conversion
PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
2018-10-22−2,306→ 0 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
2018-10-22$0.12/sh+103→ 2,306 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Warrants to Purchase Series B Preferred Stock
2018-10-22−103→ 0 total

Companies

PhaseBio Pharmaceuticals Inc
VP, Preclinical and Chem.

Recent Filings

Address

C/O PHASEBIO PHARMACEUTICALS, INC. 1 GREAT VALLEY PARKWAY, SUITE 30

MALVERN, PA, 19355

View on SEC.gov